For research use only. Not for therapeutic Use.
Barzolvolimab（Cat No.:I042162）is an investigational monoclonal antibody that targets the receptor IL-1RAP (interleukin-1 receptor accessory protein), which plays a role in mediating inflammatory responses. IL-1RAP is involved in the signaling of pro-inflammatory cytokines like IL-1 and IL-33, which contribute to various autoimmune and inflammatory diseases. By blocking IL-1RAP, barzolvolimab aims to reduce inflammation and modulate immune system activity. It is being studied in clinical trials for its potential to treat conditions like chronic inflammatory diseases, with a focus on improving symptom control and disease management in affected patients.
| Catalog Number | I042162 |
| CAS Number | 2438203-51-9 |
| Purity | ≥95% |
